-
公开(公告)号：US20100003331A1
公开(公告)日：2010-01-07
申请号：US12261678
申请日：2009-09-03
申请人： Imran Ahmed , Leah Elizabeth Appel , Walter Christian Babcock , Dwayne Thomas Friesen , Scott Herbig , David Keith Lyon , Sheri L. Shamblin , Ravi Mysore Shanker , Daniel Tod Smithey , Steven C. Sutton , Avinash Govind Thombre , Kenneth C. Waterman , Jaymin C. Shah , Parag Suresh Shah , Peter Wisniecki , Dawn Renee Wagner
发明人： Imran Ahmed , Leah Elizabeth Appel , Walter Christian Babcock , Dwayne Thomas Friesen , Scott Herbig , David Keith Lyon , Sheri L. Shamblin , Ravi Mysore Shanker , Daniel Tod Smithey , Steven C. Sutton , Avinash Govind Thombre , Kenneth C. Waterman , Jaymin C. Shah , Parag Suresh Shah , Peter Wisniecki , Dawn Renee Wagner
IPC分类号： A61K9/14 , A61K31/501
CPC分类号： A61K9/1617 , A61K9/0004 , A61K9/1652 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2077 , A61K9/2081 , A61K9/209 , A61K9/2846 , A61K9/5047 , A61K31/496 , A61K31/4965
摘要： A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
摘要翻译： 提供了用于治疗哺乳动物中的精神病症例如精神分裂症的持续释放固体口服剂型，该口服剂型包含有效治疗所述精神病性障碍的量的齐拉西酮和药学上可接受的载体。
-
2.发明申请Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle Compositions 审中-公开用于提供纳米颗粒组合物的持续释放的注射脱胶制剂和方法公开(公告)号：US20080193542A1
公开(公告)日：2008-08-14
申请号：US11911457
申请日：2006-04-10
IPC分类号： A61K31/497 , A61K9/51 , A61P25/18
CPC分类号： A61K31/496 , A61K9/0024 , A61K9/145 , A61K9/146
摘要： Pharmaceutical formulations comprising: a compound selected from the group consisting of ziprasidone, having a maximum average particle size; a carrier; and preferably at least two surface stabilizers are disclosed. The present invention also comprises methods of treating psychosis with such a formulation and processes for making such a formulation.
摘要翻译： 药物制剂，其包含：选自具有最大平均粒径的齐拉西酮的化合物; 承运人 并且优选地公开至少两个表面稳定剂。 本发明还包括用这种制剂治疗精神病的方法和制备这种制剂的方法。
-
3.发明申请INJECTABLE DEPOT FORMULATIONS AND METHODS FOR PROVIDING SUSTAINED RELEASE OF NANOPARTICLE COMPOSITIONS 审中-公开用于提供纳米复合材料的持续释放的注射剂配方和方法公开(公告)号：US20080305161A1
公开(公告)日：2008-12-11
申请号：US12043014
申请日：2008-03-05
CPC分类号： A61K9/145 , A61K9/0019 , A61K9/19 , A61K31/496 , A61K31/501
摘要： Pharmaceutical formulations comprising: a compound selected from the group consisting of ziprasidone, having a maximum average particle size; a carrier; and preferably at least two surface stabilizers are disclosed. The present invention also comprises methods of treating psychosis with such a formulation and processes for making such a formulation.
摘要翻译： 药物制剂，其包含：选自具有最大平均粒径的齐拉西酮的化合物; 承运人 并且优选地公开至少两个表面稳定剂。 本发明还包括用这种制剂治疗精神病的方法和制备这种制剂的方法。
-
-
搜索结果
3 条记录 (耗时 0.062 秒)
